Coverage / GHRS / Trade Card

GHRS

GH Research PLC

OPPORTUNISTIC BUY 2026-08-08 Data 35 days old USD 30.27 Healthcare - BiotechnologyAWAIT ENTRY
ACTIONABLEMethodology gates passed
54

Position levels

Currenttoday
USD 30.27
Buy <=wait / entry
USD 20.00
Trim >=take some off
USD 32.00
Thesis breakA formal reaffirmation or extension of the FDA clinical hold on the GH001 IND, a...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case19%100 / 10019.0
Base case51%62 / 10031.6
Bear case30%10 / 1003.0
Weighted conviction54 / 100 - OPPORTUNISTIC BUY

Top risks

  • Alignment with FDA on CMC and device plans for Phase 3
  • Completed GH001-HV-106 and GH001-HV-109 Phase 1 trials
  • Publication of Phase 2a PPD and Phase 2b TRD results
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.